CMPS — COMPASS Pathways plc

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1816590 ·
Last close
$7.98
Market Cap
$1.13B
52W High
$15.87
52W Low
$4.88
ADV30
3,349,039
Next earnings
2026-11-03

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 0 — -54,389,000 -9,831,000 519,096,000 443,979,000 377,029,000
Jun 2026 0 — -49,789,000 -253,794,000 504,561,000 433,295,000 420,028,000
Mar 2026 0 — -40,427,000 91,202,000 531,739,000 466,010,000 205,052,000
Dec 2025 0 — -58,864,000 -93,878,000 210,349,000 149,608,000 263,197,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-176,799,000
Investing CF
—
Financing CF
$433,292,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-3.49
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-995,017,000
Inventory
—
Receivables
$15,205,000
ST Investments
—
EBIT TTM
$-264,231,000
Pretax Income TTM
$-269,821,000
Interest Exp TTM
$5,590,000
Analysts
16

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 0 -175,290,000 -287,862,000 210,349,000 263,197,000 -52,848,000 -157,240,000
Dec 2024 0 -157,108,000 -155,122,000 213,666,000 58,971,000 154,695,000 -119,186,000
Dec 2023 0 -124,044,000 -118,464,000 275,987,000 50,243,000 225,744,000 -97,376,000
Dec 2022 0 -95,979,000 -91,505,000 197,294,000 16,014,000 181,280,000 -105,451,000
Dec 2021 — — — — — — —

TTM Snapshot

Revenues TTM
$9,061,000
NetIncome TTM
$-394,187,000
OpCashFlow TTM
—
Assets (Latest)
$504,561,000
Forward EPS
$-1.43

Max Pain — expiry 2026-12-18

max pain strike: $11.00 · spot: $8.12 · call oi: 1,465 · put oi: 6,304
Expected Move to 2026-12-18: ±$1.45 (17.86%) — implied range $6.67 – $9.57 · ATM straddle on $8.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
HROW HARROW, INC. $1.11B $29.52 —
MRVI MARAVAI LIFESCIENCES HOLDINGS, INC. $1.09B $7.28 —
OPK OPKO HEALTH, INC. $1.20B $1.62 —
SLNCF Silence Therapeutics plc $1.22B $6.53 —
NKTR NEKTAR THERAPEUTICS $1.23B $35.91 —

News headlines (Yahoo Finance, 1h cache)

COMPASS Pathways (CMPS) Could Be 62% Undervalued As FDA Filing Sharpens The Case
2026-11-12 20:13 · Yahoo
Compass Pathways Completes FDA Application for Psilocybin Therapy, Prepares for Launch
2026-11-12 11:13 · Yahoo
Compass Pathways to Participate in Jefferies Global Healthcare Conference on November 18th and 19th
2026-11-11 11:30 · Yahoo
Compass Pathways PLC (CMPS) (Q3 2026) Earnings Call Highlights: $444 Million Cash Runway, FDA ...
2026-11-11 05:06 · Yahoo
Compass Pathways could secure US approval for depression drug by early 2027, Jefferies says
2026-11-09 19:00 · Yahoo
Compass Pathways stock gains on FDA filing for depression drug
2026-11-09 18:09 · Yahoo
Compass Pathways Completes COMP360 Psilocybin New Drug Application to U.S. FDA for Treatment-Resistant Depression
2026-11-09 11:30 · Yahoo
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-11-05 21:30 · Yahoo
Compass Pathways to Participate in Stifel 2026 Healthcare Conference on November 11th
2026-11-04 11:30 · Yahoo
How Investors May Respond To COMPASS Pathways (CMPS) Smaller Loss And FDA Progress
2026-11-04 06:16 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.